PEPTIDE UND IHRE VERWENDUNG

European patent · EP3578193 · Deleted

Register entry

Publication number
EP3578193
Application number
EP19163975
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 30, 2011
Published
Dec 11, 2019
Granted
Sep 6, 2023
Deleted
Oct 23, 2025
Reason
Annual fee unpaid
IPC classes
A61K 38/08 (2019.01)
A61K 38/10 (2006.01)
A61K 31/145 (2006.01)
A61L 29/08 (2006.01)
C07K 7/08 (2006.01)
A61P 31/04 (2006.01)
Priority
GB 201016733 05.10.2010
WO PCT/GB2010/000631 31.03.2010
US 39008110 P 05.10.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2025

  2. Jul 17, 2024

    Change

    Published in Swissreg on 17.07.2024

  3. Apr 15, 2024

    Change

    Published in Swissreg on 15.04.2024

  4. Nov 9, 2023

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 09.11.2023

  5. Sep 6, 2023

    Granted

    Published in Swissreg on 06.09.2023

Parties

Holder

NovaBiotics Limited

Novabiotics Limited

Unit 3 Silverburn Crescent Bridge of Don, Aberdeen AB23 8EW, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

O'NEIL, Deborah

Aberdeen, AB21 9TR, GB

CHARRIER, Cedric

Aberdeen, AB21 9TR, GB

MERCER, Derry

Aberdeen, AB21 9TR, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.